Skip to content
CancerIndex

Loading the knowledge graph…

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) — knowledge graph · CancerIndex